Indication

Herpes zoster keratitis

Herpes zoster keratitis is an inflammatory corneal condition occurring as a major manifestation of herpes zoster ophthalmicus, which results from the reactivation of latent varicella-zoster virus within the ophthalmic division of the trigeminal nerve. Read more about Herpes zoster keratitis

47 drugs 25 manufacturers

Advertisement

Drugs that treat it

Common Herpes zoster keratitis therapies.

Showing 10–18 of 47 drugs

Filter & compare in the drug finder →Opens the drug finder with Herpes zoster keratitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Herpes zoster keratitis.

Herpes zoster keratitis is an inflammatory corneal condition occurring as a major manifestation of herpes zoster ophthalmicus, which results from the reactivation of latent varicella-zoster virus within the ophthalmic division of the trigeminal nerve.

It primarily affects older adults and immunocompromised individuals, involving the ocular surface and deeper corneal architecture.

Clinically, the disease can present acutely with punctate epithelial erosions and characteristic raised, mucous-rich pseudodendrites, or evolve into chronic immune-mediated stromal keratitis, endotheliitis, and neurotrophic keratopathy from sensory nerve damage.

If poorly controlled, this inflammation and associated corneal anesthesia can lead to persistent epithelial defects, stromal scarring, neovascularization, and potentially permanent vision impairment.

Personalize your experience

Follow Herpes zoster keratitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it